ArticleBMC health services research2018

Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes.

Christina S Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.